Metabolic Risks and Effects of Atypical Antipsychotic Treatment




Forgot your login? GET HELP

Weight gain and the associated increased risk of diabetes and cardiovascular disease may be problems for individuals who receive long-term treatment with atypical antipsychotics. Atypical antipsychotics differ in their propensity to cause obesity and other metabolic disturbances. If a patient gains substantial weight while taking atypical antipsychotics, the physician should consider switching him or her to a drug with a lower risk of weight gain. The physician should also address patient lifestyle issues such as poor diet and lack of exercise.

See the entire activity.

J Clin Psychiatry 2007;68(10):e24